IRLAB's Drug Candidate IRL757 Receives the Generic Name Linepemat from The WHO

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, SE / ACCESS Newswire / August 19, 2026 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company focused on discovering and developing new …